Funded Tech Companies

Aktis Oncology

Researching who provided funding to Aktis Oncology? Bristol-Myers Squibb, Mirae Asset Venture Investment and Octagon Investments Fund put venture money into this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers. Founded and incubated by MPM Capital, the company has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

8/26/2022

Financing History

Management Team

Title

Name

Email & Social

Chairman

Todd Foley

        

Chief Executive Officer

Matthew Roden

        

Company Investors

• Bristol-Myers Squibb
• Mirae Asset Venture Investment
• Octagon Investments Fund
• Cowen Capital Partners
• TCG Crossover
• EcoR1 Capital Management
• MRL Ventures
• Pappas Ventures
• MPM Capital (Todd Foley)
• Vida Ventures
• Novartis
• Timefolio Asset Management
• ArrowMark Partners
• Novartis Venture Fund

Browse more funded tech companies:

Aktino | Aktivate

Share this article

About Our Venture Capital Database

Our data comes from VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary